跳至主要内容
临床试验/NCT02455830
NCT02455830Unknown不适用

A Study to Determine if Autologous Umbilical Cord Blood Cell Therapy Alters Serum Levels of Cytokines and Trophic Factors in Neonatal Encephalopathy

Neonatal Encephalopathy Consortium, Japan6 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
18
试验地点
6
主要终点
Changes in serum levels of cytokines and trophic factors

研究概览

简要总结

This is a observational study to assess the effects of and to explore the mechanisms of autologous umbilical cord blood cell therapy for neonatal encephalopathy by way of measuring serum cytokines.

详细描述

The effects and mechanisms of umbilical cord blood cell therapy for perinatal brain injury are not well understood. This is a multicenter study to measure serum levels of inflammatory cytokines and trophic factors associated with perinatal brain injury and repair in term gestation newborns with neonatal encephalopathy (hypoxic-ischemic encephalopathy). This study proceeds along with the study "Autologous cord blood cell therapy for neonatal encephalopathy (ClinicalTrials.gov identifier: NCT02256618)". Blood samples are obtained before the first cell infusion, and subsequently 2h, 24h, 48h, and 7 days after the first cell infusion. Blood samples are obtained in the same manner from newborns with neonatal encephalopathy who are not receiving the cell therapy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 24 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • Infants are eligible if they meet all the following inclusion criteria except
  • ≥36 weeks gestation
  • Either a 10-minute Apgar score ≤5, continued need for resuscitation for at least 10 minutes, or severe acidosis, defined as pH <7.0 or base deficit ≥16 mmol/L in a sample of umbilical cord blood or any blood during the first hour after birth
  • Moderate to severe encephalopathy (Sarnat II to III)
  • A moderately or severely abnormal background amplitude-integrated EEG (aEEG) voltage, or seizures identified by aEEG, if monitored
  • Up to 24 hours of age
  • A person with parental authority must have consented for the study.

排除标准

  • Known major congenital anomalies, such as chromosomal anomalies, heart diseases
  • Major intracranial hemorrhage identified by brain ultrasonography or computed tomography
  • Severe growth restriction, with birth-weight less than 1800 g
  • Severe infectious disease, such as sepsis
  • Infants judged critically ill and unlikely to benefit from neonatal intensive care including hypothermia by the attending neonatologist

结局指标

主要结局

Changes in serum levels of cytokines and trophic factors

时间窗: From birth up to 10 days of age

次要结局

  • Association with neuroimaging and neurodevelopmental functional outcome(18 months)

研究者

发起方
Neonatal Encephalopathy Consortium, Japan
申办方类型
Network
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Cytokines Associated With Cord Blood Cell Therapy... | 临床试验